Evaluation of the recovery effects of antibiotic-resistant Lactiplantibacillus plantarum subsp. plantarum ATCC14917 on the antibiotic-disturbed intestinal microbiota using a mice model.

IF 3.2 3区 生物学 Q2 BIOTECHNOLOGY & APPLIED MICROBIOLOGY Journal of Applied Microbiology Pub Date : 2025-02-03 DOI:10.1093/jambio/lxaf020
Yiwei Wang, Bini Wang, Zhenquan Huo, Fuxin Zhang, Yufang Liu
{"title":"Evaluation of the recovery effects of antibiotic-resistant Lactiplantibacillus plantarum subsp. plantarum ATCC14917 on the antibiotic-disturbed intestinal microbiota using a mice model.","authors":"Yiwei Wang, Bini Wang, Zhenquan Huo, Fuxin Zhang, Yufang Liu","doi":"10.1093/jambio/lxaf020","DOIUrl":null,"url":null,"abstract":"<p><strong>Aims: </strong>Supplementing Lactobacillus alongside antibiotic treatment was a curative strategy to modulate gut microbiota and alleviate antibiotic-associated dysbiosis. But the lactobacilli that are used as probiotics are sensitive or have a low level of resistance to antibiotics, so they usually cannot achieve their beneficial effect, since they are killed by the applied antibiotics. This work aimed to develop the highly resistant Lactiplantibacillus plantarum subsp. plantarum ATCC14917 to cephalexin and evaluate its recovery effects of antibiotic-resistant L. plantarum on the antibiotic-disturbed intestinal microbiota using a mice model.</p><p><strong>Methods and results: </strong>After successive growth in lactic acid bacteria susceptibility medium broth containing a gradually increasing concentration of cephalexin for 70 days, the minimum inhibitory concentration (MIC) of L. plantarum ATCC14917 to cephalexin significantly increased from 16 to 8192 μg ml-1, but stabilized at 4096 μg ml-1. After sequencing and sequence analysis, no mutated genes were detected on mobile elements, showing that horizontal transfer of mutated genes could not occur. Compared to the control group (Con), feeding mice with cephalexin (1 mg ml-1; Cep) led to a decrease in alpha diversity. However, concurrently used cephalexin and L. plantarum (Cep + LpR) increased the alpha diversity in both microbial richness and diversity. The Cep + LpR group showed a lower distance with the Con group than either Cep or Cep + LpS groups, suggesting that resistant L. plantarum treatment was more effective than the original strain for the recovery of intestinal microbiota. Compared to the cephalexin-treated group, concurrent ingestion of cephalexin together with resistant L. plantarum significantly increased the proportion of beneficial bacteria and decreased Firmicutes/Bacteroidetes ratio and abundance of potential pathogens.</p><p><strong>Conclusions: </strong>The use of antibiotic-resistant L. plantarum ATCC14917 contributed to a much faster and richer recovery of the gut microbiota disturbed by antibiotic treatment compared to the original strain.</p>","PeriodicalId":15036,"journal":{"name":"Journal of Applied Microbiology","volume":" ","pages":""},"PeriodicalIF":3.2000,"publicationDate":"2025-02-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Applied Microbiology","FirstCategoryId":"99","ListUrlMain":"https://doi.org/10.1093/jambio/lxaf020","RegionNum":3,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"BIOTECHNOLOGY & APPLIED MICROBIOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Aims: Supplementing Lactobacillus alongside antibiotic treatment was a curative strategy to modulate gut microbiota and alleviate antibiotic-associated dysbiosis. But the lactobacilli that are used as probiotics are sensitive or have a low level of resistance to antibiotics, so they usually cannot achieve their beneficial effect, since they are killed by the applied antibiotics. This work aimed to develop the highly resistant Lactiplantibacillus plantarum subsp. plantarum ATCC14917 to cephalexin and evaluate its recovery effects of antibiotic-resistant L. plantarum on the antibiotic-disturbed intestinal microbiota using a mice model.

Methods and results: After successive growth in lactic acid bacteria susceptibility medium broth containing a gradually increasing concentration of cephalexin for 70 days, the minimum inhibitory concentration (MIC) of L. plantarum ATCC14917 to cephalexin significantly increased from 16 to 8192 μg ml-1, but stabilized at 4096 μg ml-1. After sequencing and sequence analysis, no mutated genes were detected on mobile elements, showing that horizontal transfer of mutated genes could not occur. Compared to the control group (Con), feeding mice with cephalexin (1 mg ml-1; Cep) led to a decrease in alpha diversity. However, concurrently used cephalexin and L. plantarum (Cep + LpR) increased the alpha diversity in both microbial richness and diversity. The Cep + LpR group showed a lower distance with the Con group than either Cep or Cep + LpS groups, suggesting that resistant L. plantarum treatment was more effective than the original strain for the recovery of intestinal microbiota. Compared to the cephalexin-treated group, concurrent ingestion of cephalexin together with resistant L. plantarum significantly increased the proportion of beneficial bacteria and decreased Firmicutes/Bacteroidetes ratio and abundance of potential pathogens.

Conclusions: The use of antibiotic-resistant L. plantarum ATCC14917 contributed to a much faster and richer recovery of the gut microbiota disturbed by antibiotic treatment compared to the original strain.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
耐药植物乳杆菌亚种恢复效果评价。植物ATCC14917对抗生素干扰小鼠肠道菌群的影响
目的:在抗生素治疗的同时补充乳酸杆菌是一种调节肠道微生物群和缓解抗生素相关生态失调的治疗策略。但作为益生菌的乳酸菌对抗生素敏感或耐药程度较低,通常不能达到有益的效果,因为它们被应用的抗生素杀死了。本研究旨在培养具有高抗性的植物乳杆菌亚种。利用小鼠模型评价耐药植物乳杆菌ATCC14917对头孢氨苄的恢复作用。方法与结果:植物L. plantarum ATCC14917对头孢氨苄的最低抑制浓度(MIC)由16 μg·mL-1显著升高至8192 μg·mL-1,稳定在4096 μg·mL-1。经过测序和序列分析,在移动元件上未检测到突变基因,表明突变基因不可能发生水平转移。与对照组(Con)相比,给小鼠灌胃头孢氨苄(1 mg·mL-1;Cep)导致α多样性降低。而同时使用头孢氨苄和L. plantarum (Cep + LpR)在微生物丰富度和多样性上均增加了α多样性。与Cep和Cep + LpS组相比,Cep + LpR组与Con组的距离最小,说明耐药植物乳杆菌处理对肠道菌群的恢复比原菌株更有效。与头孢氨苄治疗组相比,头孢氨苄与耐药植物乳杆菌同时摄入显著增加了有益菌的比例,降低了厚壁菌门/拟杆菌门的比例和潜在病原体的丰度。结论:与原始菌株相比,耐药植物乳杆菌ATCC14917的使用有助于更快、更丰富地恢复受抗生素治疗干扰的肠道微生物群。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Journal of Applied Microbiology
Journal of Applied Microbiology 生物-生物工程与应用微生物
CiteScore
7.30
自引率
2.50%
发文量
427
审稿时长
2.7 months
期刊介绍: Journal of & Letters in Applied Microbiology are two of the flagship research journals of the Society for Applied Microbiology (SfAM). For more than 75 years they have been publishing top quality research and reviews in the broad field of applied microbiology. The journals are provided to all SfAM members as well as having a global online readership totalling more than 500,000 downloads per year in more than 200 countries. Submitting authors can expect fast decision and publication times, averaging 33 days to first decision and 34 days from acceptance to online publication. There are no page charges.
期刊最新文献
Construction of Engineered Bacillus velezensis XY40-1 and the role of degQ in Enhancing Fengycin Synthesis and Pepper Disease Resistance. Diketopiperazines from antagonistic Pseudomonas spp. and their activity against the root rot-causing pathogens, Aphanomyces euteiches and Fusarium avenaceum. RecO: a potential target for overcoming fluoroquinolone resistance in Pasteurella multocida. Synergistic yeast co-culture system for improved ethyl hexanoate production in Chinese baijiu fermentation. Decoding the microbiome-disease axis with interpretable graph neural networks.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1